使用GnRHantagonist(腦下垂體拮抗劑)取代hCG用於卵巢誘導破卵
主要缺點: 當期植入(fresh ET)懷孕率&活產率較低
若改採冷凍胚胎下週期再植入懷孕率&活產率無明顯差異
2015年10月30日
2015年4月18日
GnRHantagonist 造成子宮內膜雌激素&黃體接受體表現下降
GnRHantagonist 造成子宮內膜雌激素ER alpha&黃體接受體PR表現下降
This study has shown that under the effect of a GnRH antagonist and rFSH with luteal phase progesterone supplementation, there is a significant down-regulation of PR in the surface epithelium.
http://humrep.oxfordjournals.org/content/22/11/2981.full
This study has shown that under the effect of a GnRH antagonist and rFSH with luteal phase progesterone supplementation, there is a significant down-regulation of PR in the surface epithelium.
http://humrep.oxfordjournals.org/content/22/11/2981.full
2015年3月26日
於取卵後D5-7施打3天GnRHantagonist可改善OHSS
於取卵後D5-7施打3天GnRHantagonist可改善卵巢過度刺激OHSS
OHSS造成血液濃稠, MCV>45, WBC>15000, 卵巢>10cm,
http://humrep.oxfordjournals.org/content/22/5/1348.full
http://humrep.oxfordjournals.org/content/28/7/1929.full
OHSS造成血液濃稠, MCV>45, WBC>15000, 卵巢>10cm,
http://humrep.oxfordjournals.org/content/22/5/1348.full
http://humrep.oxfordjournals.org/content/28/7/1929.full
2014年4月7日
GnRHantagonist療程不需事前使用pill
GnRHantagonist療程不需事前使用pill
使用pill 並不明顯提高懷孕率
反而提高COH劑量
http://www.ncbi.nlm.nih.gov/pubmed/18054003?dopt=Abstract
2013年8月23日
2013年6月23日
GnRHantagonist不需提早在誘導排卵早期施打
提早施打GnRHantagonist (月經第2天)比常規施打GnRHantagonist (月經第7天)
臨床結果並無統計差異
http://www.ncbi.nlm.nih.gov/pubmed/24129613
臨床結果並無統計差異
http://www.ncbi.nlm.nih.gov/pubmed/24129613
2013年5月24日
COH期間LH上升後施打GnRHantagonist可達類似懷孕率
誘導排卵COHGnRHa長療程與GnRHantagonist比較
GnRHantagonist卵子數量略少於GnRHa長療程(7.9 and 9.6)
COH期間LH上升後可能伴隨著P4上升,
但立即施打GnRHantagonist可有效控制LH達到類似懷孕率
a rise in LH accompanied by a rise in progesterone concentration during ganirelix treatment was observed in only one subject.
Prior to the start of ganirelix treatment, LH rises were observed in seven subjects, which were effectively suppressed by treatment with ganirelix. All seven women underwent embryo transfer and three of them achieved an ongoing pregnancy indicating that early LH rises do not affect the clinical outcome.
http://humrep.oxfordjournals.org/content/16/4/644.full
GnRHantagonist卵子數量略少於GnRHa長療程(7.9 and 9.6)
COH期間LH上升後可能伴隨著P4上升,
但立即施打GnRHantagonist可有效控制LH達到類似懷孕率
a rise in LH accompanied by a rise in progesterone concentration during ganirelix treatment was observed in only one subject.
Prior to the start of ganirelix treatment, LH rises were observed in seven subjects, which were effectively suppressed by treatment with ganirelix. All seven women underwent embryo transfer and three of them achieved an ongoing pregnancy indicating that early LH rises do not affect the clinical outcome.
http://humrep.oxfordjournals.org/content/16/4/644.full
2013年5月23日
使用GnRHantagonist並不會明顯壓抑黃體期之黃體素濃度
使用GnRHantagonist並不會明顯壓抑黃體期之黃體素P4濃度
使用GnRHantagonist會明顯壓抑黃體期之雌激素E2濃度
http://humrep.oxfordjournals.org/content/16/11/2258.full
使用GnRHantagonist會明顯壓抑黃體期之雌激素E2濃度
http://humrep.oxfordjournals.org/content/16/11/2258.full
2012年10月22日
高齡病患GnRHantagonist優於GnRHagonist短療程
高齡, 卵巢反應不佳,卵巢功能衰退之病患,使用GnRHantagonist取代GnRHagonist短療程可能可達到較佳之懷孕率
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3455641/pdf/10815_2004_Article_477339.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3455641/pdf/10815_2004_Article_477339.pdf
訂閱:
文章 (Atom)